Cargando…

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling

Detalles Bibliográficos
Autores principales:	Abdel-Aty, Hassan, Giannitsis, Evangelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559716/ http://dx.doi.org/10.1186/1532-429X-15-S1-P146

Ejemplares similares

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

Non-invasive measurement of myocardial extracellular volume using T1 mapping as a novel biomarker of diffuse fibrosis in dilated cardiomyopathy
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Influence of presence and patterns of late gadolinium enhancement on left ventricular remodeling after heart transplantation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Myocardial late gadolinium enhancement in systemic lupus erythematosus as a marker of chronic inflammation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Comparison of the amount of affected myocardium quantified by late gadolinium enhancement and the degree of myocardial necrosis measured by cardiac troponin T in patients with myocarditis
por: Andre, Florian, et al.
Publicado: (2013)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

The study about the difference of extra cellular volume calculated with T1mapping in dilated cardiomyopathy with and without late gadolinium enhancement
por: Teraoka, Kunihiko, et al.
Publicado: (2015)

Characteristics and clinical associations of late gadolinium enhanced cardiovascular magnetic tesonance in lamin A/C, cardiac troponin T and myosin binding protein C gene mutation related cardiomyopathies
por: Franke, Jennifer, et al.
Publicado: (2013)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Extent of late gadolinium enhancement in patients with hypertrophic cardiomyopathy in correlation with serum MMP9 as an indicator of myocardial fibrosis
por: Avanesov, Maxim, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2013)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
por: Rudolph, Andre, et al.
Publicado: (2009)

Late gadolinium enhancement by cardiac magnetic resonance imaging predicts reverse remodeling in patients with non-ischemic cardiomyopathy receiving β blocker therapy
por: Kida, Keisuke, et al.
Publicado: (2011)

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging for cardiomyopathies
por: Morsbach, Fabian, et al.
Publicado: (2014)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Improved prediction of adverse events in hypertrophic cardiomyopathy with quantitative late gadolinium enhancement and myocardial strain
por: Brahmanandam, Vikram, et al.
Publicado: (2016)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

In/opposed phase imaging effectively differentiates fat from enhanced myocardium in patients with myocardial late gadolinium enhancement
por: Kleindienst, Denise, et al.
Publicado: (2009)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis
por: Weng, Zhen, et al.
Publicado: (2016)

Description of A/C gene mutation related dilated cardiomyopathy with gadolinium- enhanced magnetic resonance imaging
por: Holmström, Miia, et al.
Publicado: (2011)

Late Gadolinium Enhancement does occur in the Tako-Tsubo Cardiomyopathy - a quantitative cardiovascular magnetic resonance study
por: Hamilton-Craig, Christian, et al.
Publicado: (2011)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Impact of left ventricular late enhancement on pulmonary arterial hypertension in idiopathic dilated cardiomyopathy
por: Pérez-David, Esther, et al.
Publicado: (2015)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Late gadolinium-enhancement cardiovascular magnetic resonance imaging and angiographic characteristics of patients referred for evaluation of new onset cardiomyopathy
por: Danilov, Tatyana, et al.
Publicado: (2011)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
por: Macron, Laurent, et al.
Publicado: (2013)

The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

GEISIR: gadolinium exposure induced systemic inflammatory response in dialysis patients
por: Steen, Henning, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bv8dvjv8emqn3s6ksa7vh31iau